- Home
- ZURA vs ZYXI Comparison
ZURA vs ZYXI Comparison
Compare ZURA & ZYXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZURA
- ZYXI
- Stock Information
- Founded
- ZURA 2022
- ZYXI 1996
- Country
- ZURA United States
- ZYXI United States
- Employees
- ZURA N/A
- ZYXI N/A
- Industry
- ZURA Biotechnology: Biological Products (No Diagnostic Substances)
- ZYXI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- ZURA Health Care
- ZYXI Health Care
- Exchange
- ZURA Nasdaq
- ZYXI Nasdaq
- Market Cap
- ZURA 61.9M
- ZYXI 66.5M
- IPO Year
- ZURA N/A
- ZYXI N/A
- Fundamental
- Price
- ZURA $1.13
- ZYXI $2.49
- Analyst Decision
- ZURA Buy
- ZYXI Buy
- Analyst Count
- ZURA 7
- ZYXI 3
- Target Price
- ZURA $14.33
- ZYXI $6.00
- AVG Volume (30 Days)
- ZURA 545.9K
- ZYXI 204.8K
- Earning Date
- ZURA 08-08-2025
- ZYXI 07-24-2025
- Dividend Yield
- ZURA N/A
- ZYXI N/A
- EPS Growth
- ZURA N/A
- ZYXI N/A
- EPS
- ZURA N/A
- ZYXI N/A
- Revenue
- ZURA N/A
- ZYXI $172,401,000.00
- Revenue This Year
- ZURA N/A
- ZYXI N/A
- Revenue Next Year
- ZURA N/A
- ZYXI $19.55
- P/E Ratio
- ZURA N/A
- ZYXI N/A
- Revenue Growth
- ZURA N/A
- ZYXI N/A
- 52 Week Low
- ZURA $0.97
- ZYXI $1.66
- 52 Week High
- ZURA $5.07
- ZYXI $10.62
- Technical
- Relative Strength Index (RSI)
- ZURA 45.37
- ZYXI 56.22
- Support Level
- ZURA $1.10
- ZYXI $1.99
- Resistance Level
- ZURA $1.37
- ZYXI $2.47
- Average True Range (ATR)
- ZURA 0.09
- ZYXI 0.15
- MACD
- ZURA 0.00
- ZYXI 0.04
- Stochastic Oscillator
- ZURA 37.18
- ZYXI 91.46
About ZURA Zura Bio Limited
Zura Bio Ltd is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. It is developing three assets which have completed Phase I/Ib studies and are Phase II ready. It is developing a portfolio of therapeutic indications for tibulizumab and torudokimab with a goal of demonstrating their efficacy, safety, and dosing convenience in autoimmune and inflammatory diseases.
About ZYXI Zynex Inc.
Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufactures, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company operates business as one operating segment which includes two revenue types: Devices and Supplies. Its markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave, and others.